Generics and access to influenza treatment
Influenza A (H1N1): Generic production must be part of solution for access to influenza medicines
(E)
AccessInfo
|
If the new influenza virus spreads to developing countries, many may find they don't have adequate treatments available. Patent blockages mustn't be allowed to deny access to life-saving medicines whether for influenza, HIV/AIDS, TB or other diseases.
